Tibet Rhodiola Pharmaceutical Holding Co
SSE:600211
Tibet Rhodiola Pharmaceutical Holding Co
Income to Minority Interest
Tibet Rhodiola Pharmaceutical Holding Co
Income to Minority Interest Peer Comparison
Competitive Income to Minority Interest Analysis
Latest Figures & CAGR of Competitors
Company | Income to Minority Interest | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Tibet Rhodiola Pharmaceutical Holding Co
SSE:600211
|
Income to Minority Interest
-¥9.3m
|
CAGR 3-Years
-53%
|
CAGR 5-Years
-30%
|
CAGR 10-Years
N/A
|
|
Sinopharm Group Co Ltd
HKEX:1099
|
Income to Minority Interest
-¥6.1B
|
CAGR 3-Years
-12%
|
CAGR 5-Years
-12%
|
CAGR 10-Years
-18%
|
|
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
Income to Minority Interest
-¥1.4B
|
CAGR 3-Years
-8%
|
CAGR 5-Years
-19%
|
CAGR 10-Years
-14%
|
|
Jointown Pharmaceutical Group Co Ltd
SSE:600998
|
Income to Minority Interest
-¥82.8m
|
CAGR 3-Years
35%
|
CAGR 5-Years
-32%
|
CAGR 10-Years
N/A
|
|
C
|
China National Medicines Corp Ltd
SSE:600511
|
Income to Minority Interest
-¥188.5m
|
CAGR 3-Years
-14%
|
CAGR 5-Years
0%
|
CAGR 10-Years
-31%
|
Huadong Medicine Co Ltd
SZSE:000963
|
Income to Minority Interest
-¥13.1m
|
CAGR 3-Years
47%
|
CAGR 5-Years
37%
|
CAGR 10-Years
23%
|
See Also
What is Tibet Rhodiola Pharmaceutical Holding Co's Income to Minority Interest?
Income to Minority Interest
-9.3m
CNY
Based on the financial report for Dec 31, 2023, Tibet Rhodiola Pharmaceutical Holding Co's Income to Minority Interest amounts to -9.3m CNY.
What is Tibet Rhodiola Pharmaceutical Holding Co's Income to Minority Interest growth rate?
Income to Minority Interest CAGR 5Y
-30%
Over the last year, the Income to Minority Interest growth was -71%. The average annual Income to Minority Interest growth rates for Tibet Rhodiola Pharmaceutical Holding Co have been -53% over the past three years , -30% over the past five years .